Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-080617

Chief Medical Officer gave up 1,428 shares (to pay taxes)

  • Chief Medical Officer acquired 2,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2024-07-15 Option exercise +2,813 47,299 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2024-07-15 Shares withheld for taxes −1,428 $8.68 $12,395 45,871 D
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2024-07-15 Option exercise · Restricted Stock Units −2,813 5,626 D
Loading xslF345X05/tm2419709-2_4seq1.xml…